SuperworthActinium Pharmaceuticals shares outstanding ATNM
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 31.4M
- On a year earlier
- +0.7%
- more shares
Actinium Pharmaceuticals had 31.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 0.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 31.2M | +0% |
| FY2024 | 31.2M | +14% |
| FY2023 | 27.4M | +8% |
| FY2022 | 25.5M | +15% |
| FY2021 | 22.1M | +39% |
| FY2020 | 15.9M | +189% |
| FY2019 | 5.5M | +44% |
| FY2018 | 3.8M | +43% |
| FY2017 | 2.7M | +44% |
| FY2016 | 1.8M | +34% |
| FY2015 | 1.4M | +39% |
| FY2014 | 993.6K | +25% |
| FY2013 | 793.1K | +1088% |
| FY2012 | 66.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 31.4M | +1% | |
| Q1 FY26 | 31.2M | +0% | |
| Q4 FY25 | 31.2M | +0% | |
| Q3 FY25 | 31.2M | +0% | |
| Q2 FY25 | 31.2M | +4% | |
| Q1 FY25 | 31.2M | +12% | |
| Q4 FY24 | 31.2M | +14% | |
| Q3 FY24 | 31.1M | +15% | |
| Q2 FY24 | 30.1M | +15% | |
| Q1 FY24 | 27.9M | +9% | |
| Q4 FY23 | 27.4M | +8% | |
| Q3 FY23 | 27.1M | +8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Actinium Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.